Article
Combined p53/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability.
Cell death and differentiation - 1 Apr 2003
Mrózek A, Petrowsky H, Sturm I, Kraus J, Hermann S, Hauptmann S, Lorenz M, Dörken B, Daniel P T
Abstract excerpt
Gastric cancer is highly refractory to DNA-damaging therapies. We therefore studied both gene mutation and protein expression of p53 and Bax in a cohort of 116 patients with gastric cancer who underwent R0-resection with a curative intent. Bax mutation was independent from severe microsatellite instability (MSI), that is, global mismatch repair deficiency as determined by analysis of BAT-25/BAT-26 microsatellite...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
